An Immunoreceptor-Targeting Strategy with Minimalistic C3b Peptide Fusion Enhances SARS-CoV-2 RBD mRNA Vaccine Immunogenicity.
Chun-Ta ChiuHsiao-Han TsaiJing-Yuan ChenChe-Ming Jack HuHui-Wen ChenPublished in: International journal of nanomedicine (2024)
The study demonstrates a novel C3b-based antigen design strategy for immune cell targeting and mRNA vaccine enhancement.